Approximately 3–5% of patients with breast cancer and 8–17% of patients with ovarian cancer can attribute the cancer to germline pathogenic variants in the BRCA1 and BRCA2 genes [22–25], which is called the hereditary breast-ovarian cancer (HBOC) syndrome [24]. This evidence concerns the gene BRCA1 and ovarian cancer.